ATE410415T1 - Neue verbindungen - Google Patents

Neue verbindungen

Info

Publication number
ATE410415T1
ATE410415T1 AT04714652T AT04714652T ATE410415T1 AT E410415 T1 ATE410415 T1 AT E410415T1 AT 04714652 T AT04714652 T AT 04714652T AT 04714652 T AT04714652 T AT 04714652T AT E410415 T1 ATE410415 T1 AT E410415T1
Authority
AT
Austria
Prior art keywords
anilinopyrazoles
new connections
treatment
relates
present
Prior art date
Application number
AT04714652T
Other languages
English (en)
Inventor
Jun Tang
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE410415T1 publication Critical patent/ATE410415T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT04714652T 2003-02-27 2004-02-25 Neue verbindungen ATE410415T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45036503P 2003-02-27 2003-02-27

Publications (1)

Publication Number Publication Date
ATE410415T1 true ATE410415T1 (de) 2008-10-15

Family

ID=32927642

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04714652T ATE410415T1 (de) 2003-02-27 2004-02-25 Neue verbindungen

Country Status (7)

Country Link
US (1) US7507834B2 (de)
EP (1) EP1597234B1 (de)
JP (1) JP2006519234A (de)
AT (1) ATE410415T1 (de)
DE (1) DE602004016964D1 (de)
ES (1) ES2312968T3 (de)
WO (1) WO2004076414A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2251677T3 (es) 2002-01-22 2006-05-01 Warner-Lambert Company Llc 2-(piridin-2-ilamino)-pirido(2,3-d)pirimidin-7-onas.
AR042067A1 (es) * 2002-11-27 2005-06-08 Bayer Pharmaceuticals Corp Derivados de anilinopirazol utiles en el tratamiento de la diabetes
ATE412650T1 (de) * 2003-07-11 2008-11-15 Warner Lambert Co Isethionat salz eines selektiven cdk4 inhibitors
WO2006105386A1 (en) * 2005-03-30 2006-10-05 Genentech, Inc. Cdk2 inhibitors
US8244844B2 (en) * 2006-03-17 2012-08-14 Samsung Electronics Co., Ltd. Tool for data generation for simple network management protocol (SNMP)
AU2022271290A1 (en) 2021-05-07 2023-11-23 Kymera Therapeutics, Inc. Cdk2 degraders and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0248523B1 (de) * 1986-05-07 1991-10-16 FISONS plc Pyrazole
US5486534A (en) 1994-07-21 1996-01-23 G. D. Searle & Co. 3,4-substituted pyrazoles for the treatment of inflammation
JP2004501083A (ja) 2000-04-18 2004-01-15 アゴーロン・ファーマシューティカルズ・インコーポレイテッド プロテインキナーゼを阻害するためのピラゾール
IL154016A0 (en) * 2000-08-31 2003-07-31 Pfizer Prod Inc Pyrazole derivatives and their use as protein kinase inhibitors

Also Published As

Publication number Publication date
US20060142284A1 (en) 2006-06-29
JP2006519234A (ja) 2006-08-24
US7507834B2 (en) 2009-03-24
EP1597234B1 (de) 2008-10-08
EP1597234A4 (de) 2007-11-21
EP1597234A2 (de) 2005-11-23
WO2004076414A2 (en) 2004-09-10
ES2312968T3 (es) 2009-03-01
WO2004076414A3 (en) 2004-10-14
DE602004016964D1 (de) 2008-11-20

Similar Documents

Publication Publication Date Title
ATE451376T1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
ATE416177T1 (de) Hetaryloxy-substituierte phenylaminopyrimidine als rho-kinasehemmer
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
ATE433973T1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
NO20082026L (no) Deazapuriner som er nyttige som inhibitorer for Janus-kinaser
ATE482213T1 (de) Als inhibitoren von proteinkinasen geeignete pyrazoloä1,5-aüpyrimidine
NO20083501L (no) Azaindoler som er anvendelige som inhibitorer for Janus-kinaser
EA200870019A1 (ru) Лактамовые соединения и способы их применения
DE60314603D1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
ATE466580T1 (de) Azolylaminoazine als proteinkinasehemmer
ATE468336T1 (de) Azolylaminoazine als proteinkinasehemmer
MXPA05010711A (es) Compuestos y composiciones novedosos como inhibidores de proteina-quinasa.
TW200510416A (en) P38 inhibitors and methods of use thereof
ATE464303T1 (de) Als inhibitoren von rock und anderen proteinkinasen geeignete zusammensetzungen
NO20064976L (no) Azanidoler som er nyttige som inhibitorer av rock og andre proteinkinaser
IL184898A0 (en) Pyrrolopyrimidine derivatives and pharmaceutical compositions containing the same
TW200633980A (en) Pyridones useful as inhibitors of kinases
ATE450530T1 (de) Zusammensetzungen zur verwendung als protein- kinase-inhibitoren
TW200606162A (en) Pyrazolopyridine derivatives
MX2009010127A (es) Compuestos utiles como inhibidores de janus cinasas.
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
ATE432260T1 (de) Pyridinderivate als pkc-theta-hemmer
ATE422201T1 (de) 4-(heterocyclyl)-benzenesulfoximin verbindungen zur behandlung entzündlicher erkrankungenen
ATE435858T1 (de) Prodrugs von als erk-proteinkinase-inhibitoren wirkenden pyrrolylpyrimidinen
ATE410415T1 (de) Neue verbindungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties